nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—PLG—artery—uterine cancer	0.0722	0.254	CbGeAlD
Tranexamic Acid—PLG—epithelium—uterine cancer	0.0274	0.0963	CbGeAlD
Tranexamic Acid—PLG—smooth muscle tissue—uterine cancer	0.0264	0.0928	CbGeAlD
Tranexamic Acid—PLG—renal system—uterine cancer	0.0254	0.0894	CbGeAlD
Tranexamic Acid—PLG—endometrium—uterine cancer	0.0246	0.0864	CbGeAlD
Tranexamic Acid—PLG—uterus—uterine cancer	0.0226	0.0796	CbGeAlD
Tranexamic Acid—PLG—female reproductive system—uterine cancer	0.0203	0.0716	CbGeAlD
Tranexamic Acid—PLG—female gonad—uterine cancer	0.0185	0.0651	CbGeAlD
Tranexamic Acid—SLC15A2—uterine cervix—uterine cancer	0.00869	0.0306	CbGeAlD
Tranexamic Acid—SLC15A2—renal system—uterine cancer	0.00813	0.0286	CbGeAlD
Tranexamic Acid—SLC15A2—endometrium—uterine cancer	0.00786	0.0276	CbGeAlD
Tranexamic Acid—SLC15A2—female reproductive system—uterine cancer	0.00651	0.0229	CbGeAlD
Tranexamic Acid—SLC15A2—female gonad—uterine cancer	0.00592	0.0208	CbGeAlD
Tranexamic Acid—SLC15A2—vagina—uterine cancer	0.00589	0.0207	CbGeAlD
Tranexamic Acid—Visual disturbance—Medroxyprogesterone Acetate—uterine cancer	0.00439	0.00629	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.00429	0.00616	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Medroxyprogesterone Acetate—uterine cancer	0.00424	0.00609	CcSEcCtD
Tranexamic Acid—Cramp muscle—Progesterone—uterine cancer	0.00413	0.00593	CcSEcCtD
Tranexamic Acid—Migraine—Medroxyprogesterone Acetate—uterine cancer	0.00409	0.00587	CcSEcCtD
Tranexamic Acid—Angina pectoris—Progesterone—uterine cancer	0.00386	0.00554	CcSEcCtD
Tranexamic Acid—SLC15A2—lymph node—uterine cancer	0.00381	0.0134	CbGeAlD
Tranexamic Acid—Abdominal discomfort—Progesterone—uterine cancer	0.0038	0.00545	CcSEcCtD
Tranexamic Acid—Cramp muscle—Medroxyprogesterone Acetate—uterine cancer	0.00374	0.00537	CcSEcCtD
Tranexamic Acid—Cardiovascular disorder—Etoposide—uterine cancer	0.00368	0.00528	CcSEcCtD
Tranexamic Acid—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00344	0.00494	CcSEcCtD
Tranexamic Acid—Venous thrombosis—Epirubicin—uterine cancer	0.00336	0.00482	CcSEcCtD
Tranexamic Acid—Sinusitis—Progesterone—uterine cancer	0.00332	0.00476	CcSEcCtD
Tranexamic Acid—Haemoglobin—Progesterone—uterine cancer	0.00319	0.00458	CcSEcCtD
Tranexamic Acid—Haemorrhage—Progesterone—uterine cancer	0.00317	0.00455	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.00316	0.00453	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.00314	0.00451	CcSEcCtD
Tranexamic Acid—Venous thrombosis—Doxorubicin—uterine cancer	0.00311	0.00446	CcSEcCtD
Tranexamic Acid—Visual impairment—Progesterone—uterine cancer	0.00306	0.00439	CcSEcCtD
Tranexamic Acid—Sinusitis—Medroxyprogesterone Acetate—uterine cancer	0.003	0.00431	CcSEcCtD
Tranexamic Acid—Eye disorder—Progesterone—uterine cancer	0.00297	0.00426	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Progesterone—uterine cancer	0.00294	0.00423	CcSEcCtD
Tranexamic Acid—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.00289	0.00415	CcSEcCtD
Tranexamic Acid—Angiopathy—Progesterone—uterine cancer	0.00288	0.00413	CcSEcCtD
Tranexamic Acid—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00288	0.00413	CcSEcCtD
Tranexamic Acid—Immune system disorder—Progesterone—uterine cancer	0.00287	0.00411	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Progesterone—uterine cancer	0.00286	0.0041	CcSEcCtD
Tranexamic Acid—Embolism—Epirubicin—uterine cancer	0.00282	0.00405	CcSEcCtD
Tranexamic Acid—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.00277	0.00398	CcSEcCtD
Tranexamic Acid—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00269	0.00386	CcSEcCtD
Tranexamic Acid—Back pain—Progesterone—uterine cancer	0.00267	0.00383	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00267	0.00383	CcSEcCtD
Tranexamic Acid—Swelling—Etoposide—uterine cancer	0.00266	0.00382	CcSEcCtD
Tranexamic Acid—Muscle spasms—Progesterone—uterine cancer	0.00266	0.00381	CcSEcCtD
Tranexamic Acid—Embolism—Doxorubicin—uterine cancer	0.00261	0.00375	CcSEcCtD
Tranexamic Acid—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00261	0.00374	CcSEcCtD
Tranexamic Acid—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.0026	0.00373	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00259	0.00372	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Progesterone—uterine cancer	0.00256	0.00368	CcSEcCtD
Tranexamic Acid—Anaemia—Progesterone—uterine cancer	0.00255	0.00366	CcSEcCtD
Tranexamic Acid—Malaise—Progesterone—uterine cancer	0.00249	0.00357	CcSEcCtD
Tranexamic Acid—Ventricular arrhythmia—Epirubicin—uterine cancer	0.00245	0.00351	CcSEcCtD
Tranexamic Acid—Dermatitis atopic—Epirubicin—uterine cancer	0.00245	0.00351	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Progesterone—uterine cancer	0.00243	0.00348	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Etoposide—uterine cancer	0.00242	0.00348	CcSEcCtD
Tranexamic Acid—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00242	0.00347	CcSEcCtD
Tranexamic Acid—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00241	0.00345	CcSEcCtD
Tranexamic Acid—Convulsion—Progesterone—uterine cancer	0.00239	0.00343	CcSEcCtD
Tranexamic Acid—Arthralgia—Progesterone—uterine cancer	0.00235	0.00337	CcSEcCtD
Tranexamic Acid—Chest pain—Progesterone—uterine cancer	0.00235	0.00337	CcSEcCtD
Tranexamic Acid—Myalgia—Progesterone—uterine cancer	0.00235	0.00337	CcSEcCtD
Tranexamic Acid—Discomfort—Progesterone—uterine cancer	0.00232	0.00333	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.00333	CcSEcCtD
Tranexamic Acid—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00231	0.00332	CcSEcCtD
Tranexamic Acid—Dermatitis atopic—Doxorubicin—uterine cancer	0.00227	0.00325	CcSEcCtD
Tranexamic Acid—Ventricular arrhythmia—Doxorubicin—uterine cancer	0.00227	0.00325	CcSEcCtD
Tranexamic Acid—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00226	0.00324	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Progesterone—uterine cancer	0.00225	0.00323	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Progesterone—uterine cancer	0.00221	0.00317	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.0022	0.00316	CcSEcCtD
Tranexamic Acid—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00217	0.00311	CcSEcCtD
Tranexamic Acid—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.00306	CcSEcCtD
Tranexamic Acid—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.00306	CcSEcCtD
Tranexamic Acid—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.00306	CcSEcCtD
Tranexamic Acid—Cramp muscle—Etoposide—uterine cancer	0.00211	0.00303	CcSEcCtD
Tranexamic Acid—Hypotension—Progesterone—uterine cancer	0.00211	0.00302	CcSEcCtD
Tranexamic Acid—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00211	0.00302	CcSEcCtD
Tranexamic Acid—Flushing—Dactinomycin—uterine cancer	0.00208	0.00299	CcSEcCtD
Tranexamic Acid—Cardiovascular disorder—Epirubicin—uterine cancer	0.00206	0.00296	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00205	0.00295	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.00293	CcSEcCtD
Tranexamic Acid—Dyspnoea—Progesterone—uterine cancer	0.00201	0.00288	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.002	0.00287	CcSEcCtD
Tranexamic Acid—Dyspepsia—Progesterone—uterine cancer	0.00198	0.00285	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Progesterone—uterine cancer	0.00195	0.00279	CcSEcCtD
Tranexamic Acid—Fatigue—Progesterone—uterine cancer	0.00194	0.00279	CcSEcCtD
Tranexamic Acid—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00191	0.00274	CcSEcCtD
Tranexamic Acid—Cardiovascular disorder—Doxorubicin—uterine cancer	0.00191	0.00274	CcSEcCtD
Tranexamic Acid—Atrioventricular block—Epirubicin—uterine cancer	0.00187	0.00268	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00186	0.00267	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Progesterone—uterine cancer	0.00186	0.00267	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Progesterone—uterine cancer	0.00184	0.00265	CcSEcCtD
Tranexamic Acid—Musculoskeletal pain—Epirubicin—uterine cancer	0.00183	0.00263	CcSEcCtD
Tranexamic Acid—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00182	0.00261	CcSEcCtD
Tranexamic Acid—Ventricular tachycardia—Epirubicin—uterine cancer	0.00181	0.0026	CcSEcCtD
Tranexamic Acid—Pulmonary embolism—Epirubicin—uterine cancer	0.00181	0.0026	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Dactinomycin—uterine cancer	0.00181	0.0026	CcSEcCtD
Tranexamic Acid—Anaemia—Dactinomycin—uterine cancer	0.0018	0.00259	CcSEcCtD
Tranexamic Acid—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00258	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Etoposide—uterine cancer	0.00178	0.00256	CcSEcCtD
Tranexamic Acid—Abdominal pain—Progesterone—uterine cancer	0.00178	0.00256	CcSEcCtD
Tranexamic Acid—Renal failure—Etoposide—uterine cancer	0.00178	0.00255	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Etoposide—uterine cancer	0.00177	0.00254	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00253	CcSEcCtD
Tranexamic Acid—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00253	CcSEcCtD
Tranexamic Acid—Malaise—Dactinomycin—uterine cancer	0.00176	0.00253	CcSEcCtD
Tranexamic Acid—Atrioventricular block—Doxorubicin—uterine cancer	0.00173	0.00248	CcSEcCtD
Tranexamic Acid—Musculoskeletal pain—Doxorubicin—uterine cancer	0.0017	0.00243	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00242	CcSEcCtD
Tranexamic Acid—Pulmonary embolism—Doxorubicin—uterine cancer	0.00168	0.00241	CcSEcCtD
Tranexamic Acid—Ventricular tachycardia—Doxorubicin—uterine cancer	0.00168	0.00241	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00167	0.0024	CcSEcCtD
Tranexamic Acid—Myalgia—Dactinomycin—uterine cancer	0.00166	0.00239	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Progesterone—uterine cancer	0.00166	0.00238	CcSEcCtD
Tranexamic Acid—Discomfort—Dactinomycin—uterine cancer	0.00164	0.00236	CcSEcCtD
Tranexamic Acid—Asthenia—Progesterone—uterine cancer	0.00162	0.00232	CcSEcCtD
Tranexamic Acid—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00161	0.00232	CcSEcCtD
Tranexamic Acid—Pulmonary oedema—Epirubicin—uterine cancer	0.00161	0.00231	CcSEcCtD
Tranexamic Acid—Diarrhoea—Progesterone—uterine cancer	0.00154	0.00221	CcSEcCtD
Tranexamic Acid—Eye disorder—Etoposide—uterine cancer	0.00152	0.00218	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Etoposide—uterine cancer	0.00151	0.00216	CcSEcCtD
Tranexamic Acid—Flushing—Etoposide—uterine cancer	0.00151	0.00216	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00216	CcSEcCtD
Tranexamic Acid—Pulmonary oedema—Doxorubicin—uterine cancer	0.00149	0.00214	CcSEcCtD
Tranexamic Acid—Dizziness—Progesterone—uterine cancer	0.00149	0.00214	CcSEcCtD
Tranexamic Acid—Angiopathy—Etoposide—uterine cancer	0.00147	0.00211	CcSEcCtD
Tranexamic Acid—Immune system disorder—Etoposide—uterine cancer	0.00147	0.0021	CcSEcCtD
Tranexamic Acid—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.0021	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Etoposide—uterine cancer	0.00146	0.0021	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—GPX3—uterine cancer	0.00145	0.077	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00145	0.00208	CcSEcCtD
Tranexamic Acid—Vomiting—Progesterone—uterine cancer	0.00143	0.00206	CcSEcCtD
Tranexamic Acid—Headache—Progesterone—uterine cancer	0.00141	0.00203	CcSEcCtD
Tranexamic Acid—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00201	CcSEcCtD
Tranexamic Acid—Fatigue—Dactinomycin—uterine cancer	0.00137	0.00197	CcSEcCtD
Tranexamic Acid—Back pain—Etoposide—uterine cancer	0.00137	0.00196	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00136	0.00195	CcSEcCtD
Tranexamic Acid—Muscle spasms—Etoposide—uterine cancer	0.00136	0.00195	CcSEcCtD
Tranexamic Acid—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00194	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Epirubicin—uterine cancer	0.00134	0.00193	CcSEcCtD
Tranexamic Acid—Nausea—Progesterone—uterine cancer	0.00134	0.00192	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Dactinomycin—uterine cancer	0.00131	0.00188	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Etoposide—uterine cancer	0.00131	0.00188	CcSEcCtD
Tranexamic Acid—Anaemia—Etoposide—uterine cancer	0.00131	0.00187	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Dactinomycin—uterine cancer	0.0013	0.00187	CcSEcCtD
Tranexamic Acid—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00186	CcSEcCtD
Tranexamic Acid—Migraine—Epirubicin—uterine cancer	0.00129	0.00186	CcSEcCtD
Tranexamic Acid—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00184	CcSEcCtD
Tranexamic Acid—Malaise—Etoposide—uterine cancer	0.00127	0.00183	CcSEcCtD
Tranexamic Acid—Abdominal pain—Dactinomycin—uterine cancer	0.00126	0.00181	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00126	0.0018	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Etoposide—uterine cancer	0.00124	0.00178	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00124	0.00178	CcSEcCtD
Tranexamic Acid—Convulsion—Etoposide—uterine cancer	0.00122	0.00176	CcSEcCtD
Tranexamic Acid—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00174	CcSEcCtD
Tranexamic Acid—Chest pain—Etoposide—uterine cancer	0.0012	0.00173	CcSEcCtD
Tranexamic Acid—Migraine—Doxorubicin—uterine cancer	0.0012	0.00172	CcSEcCtD
Tranexamic Acid—Discomfort—Etoposide—uterine cancer	0.00119	0.00171	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Dactinomycin—uterine cancer	0.00117	0.00168	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—GPX3—uterine cancer	0.00115	0.0612	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Etoposide—uterine cancer	0.00115	0.00165	CcSEcCtD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—YWHAE—uterine cancer	0.00114	0.0606	CbGpPWpGaD
Tranexamic Acid—Asthenia—Dactinomycin—uterine cancer	0.00114	0.00164	CcSEcCtD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—DCN—uterine cancer	0.00113	0.0598	CbGpPWpGaD
Tranexamic Acid—Angina pectoris—Epirubicin—uterine cancer	0.00111	0.00159	CcSEcCtD
Tranexamic Acid—Diarrhoea—Dactinomycin—uterine cancer	0.00109	0.00156	CcSEcCtD
Tranexamic Acid—Hypotension—Etoposide—uterine cancer	0.00108	0.00155	CcSEcCtD
Tranexamic Acid—Dyspnoea—Etoposide—uterine cancer	0.00103	0.00148	CcSEcCtD
Tranexamic Acid—Angina pectoris—Doxorubicin—uterine cancer	0.00102	0.00147	CcSEcCtD
Tranexamic Acid—Vomiting—Dactinomycin—uterine cancer	0.00101	0.00145	CcSEcCtD
Tranexamic Acid—Renal failure—Epirubicin—uterine cancer	0.000996	0.00143	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Etoposide—uterine cancer	0.000996	0.00143	CcSEcCtD
Tranexamic Acid—Fatigue—Etoposide—uterine cancer	0.000994	0.00143	CcSEcCtD
Tranexamic Acid—Sinusitis—Epirubicin—uterine cancer	0.000951	0.00136	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Etoposide—uterine cancer	0.00095	0.00136	CcSEcCtD
Tranexamic Acid—Nausea—Dactinomycin—uterine cancer	0.000946	0.00136	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Etoposide—uterine cancer	0.000943	0.00135	CcSEcCtD
Tranexamic Acid—Renal failure—Doxorubicin—uterine cancer	0.000922	0.00132	CcSEcCtD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—MTHFR—uterine cancer	0.000917	0.0486	CbGpPWpGaD
Tranexamic Acid—Haemoglobin—Epirubicin—uterine cancer	0.000914	0.00131	CcSEcCtD
Tranexamic Acid—Abdominal pain—Etoposide—uterine cancer	0.000912	0.00131	CcSEcCtD
Tranexamic Acid—Haemorrhage—Epirubicin—uterine cancer	0.00091	0.00131	CcSEcCtD
Tranexamic Acid—Sinusitis—Doxorubicin—uterine cancer	0.00088	0.00126	CcSEcCtD
Tranexamic Acid—Visual impairment—Epirubicin—uterine cancer	0.000877	0.00126	CcSEcCtD
Tranexamic Acid—Eye disorder—Epirubicin—uterine cancer	0.00085	0.00122	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Etoposide—uterine cancer	0.00085	0.00122	CcSEcCtD
Tranexamic Acid—Haemoglobin—Doxorubicin—uterine cancer	0.000846	0.00121	CcSEcCtD
Tranexamic Acid—Flushing—Epirubicin—uterine cancer	0.000844	0.00121	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Epirubicin—uterine cancer	0.000844	0.00121	CcSEcCtD
Tranexamic Acid—Haemorrhage—Doxorubicin—uterine cancer	0.000842	0.00121	CcSEcCtD
Tranexamic Acid—Asthenia—Etoposide—uterine cancer	0.000827	0.00119	CcSEcCtD
Tranexamic Acid—Angiopathy—Epirubicin—uterine cancer	0.000826	0.00118	CcSEcCtD
Tranexamic Acid—Immune system disorder—Epirubicin—uterine cancer	0.000822	0.00118	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Epirubicin—uterine cancer	0.00082	0.00118	CcSEcCtD
Tranexamic Acid—Arrhythmia—Epirubicin—uterine cancer	0.000813	0.00117	CcSEcCtD
Tranexamic Acid—Visual impairment—Doxorubicin—uterine cancer	0.000811	0.00116	CcSEcCtD
Tranexamic Acid—Diarrhoea—Etoposide—uterine cancer	0.000789	0.00113	CcSEcCtD
Tranexamic Acid—Eye disorder—Doxorubicin—uterine cancer	0.000787	0.00113	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Doxorubicin—uterine cancer	0.000781	0.00112	CcSEcCtD
Tranexamic Acid—Flushing—Doxorubicin—uterine cancer	0.000781	0.00112	CcSEcCtD
Tranexamic Acid—Back pain—Epirubicin—uterine cancer	0.000766	0.0011	CcSEcCtD
Tranexamic Acid—Angiopathy—Doxorubicin—uterine cancer	0.000764	0.0011	CcSEcCtD
Tranexamic Acid—Dizziness—Etoposide—uterine cancer	0.000763	0.00109	CcSEcCtD
Tranexamic Acid—Muscle spasms—Epirubicin—uterine cancer	0.000762	0.00109	CcSEcCtD
Tranexamic Acid—Immune system disorder—Doxorubicin—uterine cancer	0.00076	0.00109	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Doxorubicin—uterine cancer	0.000759	0.00109	CcSEcCtD
Tranexamic Acid—Arrhythmia—Doxorubicin—uterine cancer	0.000752	0.00108	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—MTHFR—uterine cancer	0.000746	0.0396	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Epirubicin—uterine cancer	0.000735	0.00105	CcSEcCtD
Tranexamic Acid—Vomiting—Etoposide—uterine cancer	0.000733	0.00105	CcSEcCtD
Tranexamic Acid—Anaemia—Epirubicin—uterine cancer	0.000732	0.00105	CcSEcCtD
Tranexamic Acid—Headache—Etoposide—uterine cancer	0.000722	0.00104	CcSEcCtD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—CCL2—uterine cancer	0.000718	0.038	CbGpPWpGaD
Tranexamic Acid—Malaise—Epirubicin—uterine cancer	0.000714	0.00102	CcSEcCtD
Tranexamic Acid—Back pain—Doxorubicin—uterine cancer	0.000709	0.00102	CcSEcCtD
Tranexamic Acid—Muscle spasms—Doxorubicin—uterine cancer	0.000705	0.00101	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Epirubicin—uterine cancer	0.000696	0.000999	CcSEcCtD
Tranexamic Acid—Convulsion—Epirubicin—uterine cancer	0.000686	0.000985	CcSEcCtD
Tranexamic Acid—Nausea—Etoposide—uterine cancer	0.000685	0.000983	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Doxorubicin—uterine cancer	0.00068	0.000976	CcSEcCtD
Tranexamic Acid—Anaemia—Doxorubicin—uterine cancer	0.000677	0.000972	CcSEcCtD
Tranexamic Acid—Arthralgia—Epirubicin—uterine cancer	0.000674	0.000968	CcSEcCtD
Tranexamic Acid—Chest pain—Epirubicin—uterine cancer	0.000674	0.000968	CcSEcCtD
Tranexamic Acid—Myalgia—Epirubicin—uterine cancer	0.000674	0.000968	CcSEcCtD
Tranexamic Acid—Discomfort—Epirubicin—uterine cancer	0.000666	0.000956	CcSEcCtD
Tranexamic Acid—Malaise—Doxorubicin—uterine cancer	0.000661	0.000948	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Epirubicin—uterine cancer	0.000646	0.000928	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Doxorubicin—uterine cancer	0.000644	0.000924	CcSEcCtD
Tranexamic Acid—Convulsion—Doxorubicin—uterine cancer	0.000635	0.000911	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—TSPYL2—uterine cancer	0.000635	0.0336	CbGpPWpGaD
Tranexamic Acid—Nervous system disorder—Epirubicin—uterine cancer	0.000634	0.00091	CcSEcCtD
Tranexamic Acid—Myalgia—Doxorubicin—uterine cancer	0.000624	0.000895	CcSEcCtD
Tranexamic Acid—Chest pain—Doxorubicin—uterine cancer	0.000624	0.000895	CcSEcCtD
Tranexamic Acid—Arthralgia—Doxorubicin—uterine cancer	0.000624	0.000895	CcSEcCtD
Tranexamic Acid—Discomfort—Doxorubicin—uterine cancer	0.000616	0.000885	CcSEcCtD
Tranexamic Acid—Hypotension—Epirubicin—uterine cancer	0.000604	0.000867	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Doxorubicin—uterine cancer	0.000598	0.000858	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000593	0.0314	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000589	0.000845	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Doxorubicin—uterine cancer	0.000587	0.000842	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—CCL2—uterine cancer	0.000584	0.0309	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Epirubicin—uterine cancer	0.000576	0.000827	CcSEcCtD
Tranexamic Acid—Dyspepsia—Epirubicin—uterine cancer	0.000569	0.000817	CcSEcCtD
Tranexamic Acid—Hypotension—Doxorubicin—uterine cancer	0.000559	0.000802	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000558	0.000801	CcSEcCtD
Tranexamic Acid—Fatigue—Epirubicin—uterine cancer	0.000557	0.0008	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000545	0.000782	CcSEcCtD
Tranexamic Acid—Dyspnoea—Doxorubicin—uterine cancer	0.000533	0.000765	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Epirubicin—uterine cancer	0.000533	0.000764	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Epirubicin—uterine cancer	0.000529	0.000759	CcSEcCtD
Tranexamic Acid—Dyspepsia—Doxorubicin—uterine cancer	0.000527	0.000756	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000516	0.000741	CcSEcCtD
Tranexamic Acid—Fatigue—Doxorubicin—uterine cancer	0.000516	0.00074	CcSEcCtD
Tranexamic Acid—Abdominal pain—Epirubicin—uterine cancer	0.000511	0.000733	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Doxorubicin—uterine cancer	0.000493	0.000707	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000489	0.000702	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Epirubicin—uterine cancer	0.000476	0.000683	CcSEcCtD
Tranexamic Acid—Abdominal pain—Doxorubicin—uterine cancer	0.000473	0.000679	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—DCN—uterine cancer	0.000473	0.025	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—CCL2—uterine cancer	0.000464	0.0246	CbGpPWpGaD
Tranexamic Acid—Asthenia—Epirubicin—uterine cancer	0.000464	0.000666	CcSEcCtD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CDH1—uterine cancer	0.000454	0.0241	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Epirubicin—uterine cancer	0.000442	0.000635	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Doxorubicin—uterine cancer	0.000441	0.000632	CcSEcCtD
Tranexamic Acid—Asthenia—Doxorubicin—uterine cancer	0.000429	0.000616	CcSEcCtD
Tranexamic Acid—Dizziness—Epirubicin—uterine cancer	0.000427	0.000613	CcSEcCtD
Tranexamic Acid—Vomiting—Epirubicin—uterine cancer	0.000411	0.00059	CcSEcCtD
Tranexamic Acid—Diarrhoea—Doxorubicin—uterine cancer	0.000409	0.000587	CcSEcCtD
Tranexamic Acid—Headache—Epirubicin—uterine cancer	0.000405	0.000581	CcSEcCtD
Tranexamic Acid—Dizziness—Doxorubicin—uterine cancer	0.000396	0.000568	CcSEcCtD
Tranexamic Acid—Nausea—Epirubicin—uterine cancer	0.000384	0.000551	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000383	0.0203	CbGpPWpGaD
Tranexamic Acid—Vomiting—Doxorubicin—uterine cancer	0.00038	0.000546	CcSEcCtD
Tranexamic Acid—Headache—Doxorubicin—uterine cancer	0.000375	0.000538	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—uterine cancer	0.000366	0.0194	CbGpPWpGaD
Tranexamic Acid—Nausea—Doxorubicin—uterine cancer	0.000355	0.00051	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—FGFR2—uterine cancer	0.000344	0.0183	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—VEGFA—uterine cancer	0.000322	0.017	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	0.000306	0.0162	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—AKT1—uterine cancer	0.000299	0.0158	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—INHBA—uterine cancer	0.000284	0.015	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—TP53—uterine cancer	0.000283	0.015	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—PIK3CA—uterine cancer	0.000283	0.015	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—TP53—uterine cancer	0.000273	0.0145	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MME—uterine cancer	0.000267	0.0141	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IRF1—uterine cancer	0.000249	0.0132	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—AKT1—uterine cancer	0.000231	0.0122	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000219	0.0116	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—ERBB2—uterine cancer	0.000216	0.0115	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—CDKN1B—uterine cancer	0.0002	0.0106	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—CDH1—uterine cancer	0.00019	0.0101	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PTEN—uterine cancer	0.000184	0.00977	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—FBXW7—uterine cancer	0.000175	0.00929	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—NRAS—uterine cancer	0.000165	0.00872	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKR1B10—uterine cancer	0.000161	0.00855	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	0.000143	0.00756	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—KRAS—uterine cancer	0.000142	0.0075	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RNF43—uterine cancer	0.000134	0.00708	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CA—uterine cancer	0.00013	0.00689	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—INHBA—uterine cancer	0.000122	0.00648	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—HRAS—uterine cancer	0.00012	0.00638	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	0.000111	0.0059	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKR1C1—uterine cancer	0.00011	0.00583	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—AKT1—uterine cancer	0.000106	0.00563	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—AKT1—uterine cancer	9.1e-05	0.00482	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CCL2—uterine cancer	9.01e-05	0.00477	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKR1C3—uterine cancer	8.47e-05	0.00449	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PGR—uterine cancer	8.26e-05	0.00438	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—YWHAE—uterine cancer	7.88e-05	0.00417	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—EP300—uterine cancer	7.76e-05	0.00411	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FBXW7—uterine cancer	7.55e-05	0.004	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—VEGFA—uterine cancer	7.35e-05	0.0039	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—NRAS—uterine cancer	7.26e-05	0.00385	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CXCL8—uterine cancer	7.12e-05	0.00377	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—STK11—uterine cancer	6.6e-05	0.0035	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CTNNB1—uterine cancer	6.57e-05	0.00348	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—KRAS—uterine cancer	6.25e-05	0.00331	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SOCS3—uterine cancer	6.18e-05	0.00328	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN2B—uterine cancer	5.92e-05	0.00314	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IGF1R—uterine cancer	5.75e-05	0.00304	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CA—uterine cancer	5.74e-05	0.00304	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TP53—uterine cancer	5.55e-05	0.00294	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SMAD3—uterine cancer	5.4e-05	0.00286	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—HRAS—uterine cancer	5.31e-05	0.00282	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGFR2—uterine cancer	5.15e-05	0.00273	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—AKT1—uterine cancer	4.69e-05	0.00249	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ESR1—uterine cancer	4.41e-05	0.00234	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCL2—uterine cancer	3.88e-05	0.00206	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ERBB2—uterine cancer	3.24e-05	0.00171	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCL8—uterine cancer	3.07e-05	0.00163	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN1B—uterine cancer	3e-05	0.00159	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CTNNB1—uterine cancer	2.83e-05	0.0015	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTEN—uterine cancer	2.76e-05	0.00146	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EP300—uterine cancer	2.63e-05	0.00139	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VEGFA—uterine cancer	2.49e-05	0.00132	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NRAS—uterine cancer	2.46e-05	0.0013	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KRAS—uterine cancer	2.12e-05	0.00112	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CA—uterine cancer	1.95e-05	0.00103	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TP53—uterine cancer	1.88e-05	0.000998	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HRAS—uterine cancer	1.8e-05	0.000954	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKT1—uterine cancer	1.59e-05	0.000843	CbGpPWpGaD
